Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 3/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.38 |
| ▸ | CASP1 | P29466 | 11/20 | 0.38 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.38 |
| ▸ | FPR1 | P21462 | 2/20 | 0.35 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4426794 | 0.97 | CASP1 (0.39) | CTSACASP1BDKRB2FPR1 | |
| SCHEMBL8506622 | 0.93 | CTSA (0.40) | CTSAKEAP1NFE2L2FPR1CYP26A1 | |
| SCHEMBL4435400 | 0.93 | CTSA (0.40) | CTSAKEAP1NFE2L2FPR1CYP26A1 | |
| SCHEMBL4435399 | 0.93 | CTSA (0.40) | CTSAKEAP1NFE2L2FPR1CYP26A1 | |
| SCHEMBL4431712 | 0.90 | CTSA (0.41) | CTSAKEAP1NFE2L2FPR1CYP26A1 | |
| SCHEMBL4436967 | 0.90 | CTSA (0.41) | CTSAKEAP1NFE2L2FPR1CYP26A1 | |
| SCHEMBL4431319 | 0.90 | KEAP1 (0.43) | KEAP1NFE2L2CASP1FPR1 | |
| SCHEMBL4436767 | 0.89 | CASP1 (0.39) | CASP1FPR1 | |
| SCHEMBL4425710 | 0.89 | ALDH1A1 (0.37) | CTSAKEAP1NFE2L2FPR1 | |
| SCHEMBL4426449 | 0.89 | CYP26A1 (0.39) | CTSAKEAP1NFE2L2FPR1CYP26A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1213288-B1 | Propanoic acid derivatives that inhibit the binding of integrins to their receptors | ENCYSIVE PHARMACEUTICALS INC (US) | 2009-01-14 | — | — | EP | disclosed |
| EP-1213288-A1 | Propanoic acid derivatives that inhibit the binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2002-06-12 | — | — | EP | disclosed |